Seroprevalence of seven high-risk HPV types in The Netherlands
Authors:
- Mirte ScherpenisseMSMirte Scherpenisse
- Madelief MollersMMMadelief Mollers
- Rutger M. ScheppRSRutger M. Schepp
- Hein J. BootHBHein J. Boot
- Hester E. de MelkerHMHester E. de Melker
- Chris J.L.M. MeijerCMChris J.L.M. Meijer
- Guy A.M. BerbersGBGuy A.M. Berbers
- Fiona R.M. van der KlisFKFiona R.M. van der Klis
Abstract
No abstract availableKeywords
Funding Information
- MSD
This publication has 30 references indexed in Scilit:
- HPV - immune response to infection and vaccinationInfectious Agents and Cancer, 2010
- Determinants for HPV vaccine uptake in the Netherlands: A multilevel studyVaccine, 2010
- Seroprevalence of Human Papillomavirus Types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003–2004The Journal of Infectious Diseases, 2009
- Clinician's guide to human papillomavirus immunology: knowns and unknownsThe Lancet Infectious Diseases, 2009
- Seroprevalence of 34 Human Papillomavirus Types in the German General PopulationPLOS Pathogens, 2008
- Prevalence of human papillomavirus antibodies in young female subjects in EnglandBritish Journal of Cancer, 2007
- The natural history of cervical HPV infection: unresolved issuesNature Reviews Cancer, 2007
- Stability over Time of Serum Antibody Levels to Human Papillomavirus Type 16The Journal of Infectious Diseases, 1998
- Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical DysplasiaJNCI: Journal of the National Cancer Institute, 1995
- Epidemiologic Evidence Showing That Human Papillomavirus Infection Causes Most Cervical Intraepithelial NeoplasiaJNCI: Journal of the National Cancer Institute, 1993